International Liver Congress

Meeting NewsVideo

ILC 2018 offers hope in autoimmune liver disease: PBC, PSC, hepatitis

April 14, 2018
PARIS — In this exclusive interview, Gideon M. Hirschfield, MD, PhD, from the Centre for Liver Research, University of Birmingham, discusses…
Meeting News

Value of prophylaxis for cirrhotic bacterial infections requires review

April 14, 2018
PARIS — Patients who underwent primary prophylaxis treatment for spontaneous bacterial peritonitis had poorer outcomes compared with patients…
Meeting News

8-weeks of Zepatier may effectively treat HCV genotype 4

April 14, 2018
PARIS — In patients with hepatitis C virus genotype 4, 8 weeks of Zepatier showed effective treatment of the virus, according to a presentation…
Meeting NewsVideo

ELAD shows promise in alcoholic hepatitis biomechanical response

April 14, 2018
PARIS — In a disease that has no current treatment, a plasma transfer system may offer hope to patients with alcoholic liver disease, according…
Meeting News

Alcohol, cannabis use have no impact on HCV cure rates

April 14, 2018
PARIS — Although sustained virologic response maintained a high level no matter the alcohol or cannabis consumption in a German registry, those…
Meeting News

Abstinence does not reduce HCC risk in alcoholic-related cirrhosis

April 14, 2018
PARIS — Alcohol abstinence did not reduce the risk for hepatocellular carcinoma among patients with Child-Pugh class A or B alcohol-related…
Meeting News

Web-based lifestyle intervention as effective as group programs for fatty liver

April 14, 2018
PARIS — A web-based lifestyle counselling program for patients with nonalcoholic fatty liver disease demonstrated long-term efficacy and…
Meeting NewsVideo

Women on HRT, birth control safely, effectively treated HCV with Zepatier

April 14, 2018
PARIS — Though some direct-acting antivirals conflict with the administration of hormone replacement therapy or oral contraceptives, a recent…
Meeting News

Budesonide decreases serum alkaline phosphatase in PBC

April 14, 2018
PARIS — budesonide add-on therapy to ursodeoxycholic acid did not significantly improve histology in high-risk patients with primary biliary…
Meeting News

Myrcludex B with tenofovir shows response in HDV/HBV coinfection

April 13, 2018
PARIS — Adding myrcludex B to existing tenofovir treatment in patients with hepatitis delta and hepatitis B coinfection led to virologic…